NL-OMON55069招募中不适用
PREVENTION OF VASOPLEGIA WITH THE USE OF CYTOSORB - CytoSorb-HF Trial
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •-Diagnosed with heart failure (HF) in line with the European Society of
- •Cardiology (ESC)
- •-Left ventricular ejection fraction (EF) <=35%
- •-Undergoing cardiac surgery on cardiopulmonary bypass (CPB) with an anticipated
- •duration of at least 120 minutes
- •-Age >= 18 years.
排除标准
- •-Incapacitated
- •-Emergency operation
- •-Need for moderate or high dosages of intravenous inotropic support (>4 gamma
- •dobutamine or dopamine) and/or vasopression;
- •-Severe tricuspid regurgitation;
- •-Daily use of nitroglycerine or isosorbide dinitrate
- •-Use of alpha blockers
- •-Being Heparin Induced Thrombocytopenia (HIT) positive and citrate regional*
- •anticoagulation is unavailable as an alternative anticoagulation method
- •-Platelet count < 20,000/µL.
研究者
相似试验
进行中（未招募）
1 期
Preventing caRdiovascular collapsE with VasoprEssors duriNg Tracheal IntubatiON: The PREVENTION Randomized Controlled Trial (PREVENTION trial)criticall illnessMedDRA version: 20.0Level: PTClassification code: 10077264Term: Critical illness Class: 100000004867CTIS2023-503895-25-00niversita Degli Studi Di Torino300
招募中
不适用
Prevention of Low Blood Pressure After Cardiac Surgery in Heart Failure Patients With a Filter Called CytoSorb.VasoplegiaHeart FailureNCT04812717Leiden University Medical Center36
进行中（未招募）
不适用
ANTIPLATELET TREATMENT FOR PREVENTION OF VASCULAR OUTCOMES IN PAD PATIENTS UNDERGOING PERIPHERAL REVASCULARIZATION.Will be enrolled in the study patients suffering from intermittent claudication in whom resulted ineffective both pharmacological and workout therapy- Will be considered eligible patients aged 40-80 inclusive, with an ankle-brachial index (ABI) <0.9 or > 1.3 at basal condition and diametrical arterial stenosis equal or superior to 50% vessel lumen, undergoing peripheral revascularization procedures.MedDRA version: 14.1Level: LLTClassification code 10003209Term: ArteriopathySystem Organ Class: 10047065 - Vascular disordersEUCTR2012-000997-53-ITAZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA
进行中（未招募）
1 期
Prophylaxis of venous thromboembolic disease with LMWH (TINzaparin) in patients with metastatic colorectal cancer who start the first line of treatment.Stage IV colon or rectal adenocarcinoma (mCRC).MedDRA version: 21.1Level: LLTClassification code: 10043565Term: Thromboembolic event Class: 10047065MedDRA version: 21.0Level: PTClassification code: 10052358Term: Colorectal cancer metastatic Class: 100000004864CTIS2023-508860-31-00Grupo Gallego De Investigacion En Tumores Digestivos631
进行中（未招募）
不适用
Reduction Of Microvascular Injury Utilizing SonolysisMyocardial infarctionEUCTR2014-002514-23-NLVU Medical Center